RxDoctor Payments Data

Ambrose Huang, MD

Diagnostic Radiology · Saint Louis, MONPI 1467486126

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $168,670 of the $168,670 with a category attached, or 100.0%. Pfizer accounts for 97.0% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $64,795, more than ten times the $5,000 reported in 2021. Among diagnostic radiology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$168,670in general payments, 2019–2025

Across 55 payments — averaging $3066.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$164K
  • Sanofi US Services Inc.$4K
  • Bioverativ Therapeutics Inc.$600
$228,705in research payments, 2019–2025

Across 94 payments — averaging $2433.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$71K
  • UCB Biosciences Inc.$38K
  • Janssen Research & Development, LLC$38K
  • AbbVie$25K
  • UCB SA$24K
  • Kyowa Kirin Pharmaceutical Development, Inc$21K
  • plus $12K from 2 others

What the payments were for

  • Consulting fees$168,670100%

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer49$163,670
Sanofi US Services Inc.5$4,400
Bioverativ Therapeutics Inc.1$600

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$168,670 in reported general payments places this provider in the 95th percentile of 762 diagnostic radiology providers in Missouri.

See all diagnostic radiology providers in Missouri

Medicare billing

Part B allowed, 2024
$189,063
Medicare patients
6,276
Services billed
9,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →